SEC Comment Letter for AMYRIS, INC. (CIK 0001365916) — May 20, 2020
AMYRIS, INC. (CIK 0001365916)
Date: May 20, 2020 · CIK: 0001365916 · Accession: 0000000000-20-004518
AI Filing Summary & Sentiment
File numbers found in text: 333-238188
Letter
United States securities and exchange commission logo May 20, 2020 John Melo President and Chief Executive Officer Amyris, Inc. 5885 Hollis Street, Suite 100 Emeryville, CA 94608 Re:Amyris, Inc. Registration Statement on Form S-1 Filed May 12, 2020 File No. 333-238188 Dear Mr. Melo: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Amanda L. Rose, Esq.
Show Raw Text
United States securities and exchange commission logo
May 20, 2020
John Melo
President and Chief Executive Officer
Amyris, Inc.
5885 Hollis Street, Suite 100
Emeryville, CA 94608
Re:Amyris, Inc.
Registration Statement on Form S-1
Filed May 12, 2020
File No. 333-238188
Dear Mr. Melo:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Amanda L. Rose, Esq.